Oncology/Hematology Fellowship Program

The subspecialty fellowship in hematology and medical oncology is an ACGME-accredited three-year combined program for candidates who are board eligible in internal medicine wishing to achieve certification in both hematology and medical oncology. Five of the best candidates are taken per year. Candidates rotate on five separate services within the hospital which include hematology consults, oncology consults, bone marrow transplant, leukemia service and general medical oncology/hematology providing an excellent training resource.

Fellows divide their time between covering inpatient hematology and medical oncology services, and following patients in dedicated ambulatory longitudinal clinics. Inpatient services designated "teaching services" include residents and medical students, with fellows assuming teaching responsibilities in addition to patient care responsibilities. Consult services will frequently include residents as part of the consult team. Fellows spend the majority of their first year in clinical settings. The second and third fellowship years provide fellows with ample research time, and allow for clinical specialization through senior fellow roles on inpatient services and in disease-specific outpatient clinics. Additional elective rotations are available in palliative medicine, neuro-oncology, oncologic urology, gynecologic oncology and radiation oncology, laboratory medicine, coagulation, hematopathology, and blood banking. Fellows take call during their first year on average every fifth night, and do not take in-house overnight call. A longitudinal outpatient experience includes staff-mentored clinics over the entire three years. The fellowship is flexible and can be modified, depending on the special interest of the fellow candidate.

A variety of clinical and laboratory research opportunities are available for fellow candidates. A variety of clinical projects including phase I, II, and III clinical trials, pharmacology studies, and retrospective reviews are available. In addition, a close collaboration with the Department of Cancer Biology within the Research Institute, allows fellows to explore laboratory interests. Fellows are expected to write multiple abstracts and are to be involved in the writing of a manuscript before completing the fellowship. Research opportunities are available in both basic science and clinical settings in the Taussig Cancer Institute and the Lerner Research Institute, as well as the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. Fellows identify a major research project within their first year of fellowship, and produce a minimum of two abstracts and one publishable manuscript prior to graduation. Fellows are expected to attend at least one research conference per year during their second and third years, and to present their research at one conference prior to graduation. In the past year, fellows have published more than 30 manuscripts or abstracts and have given 15 presentations at national and international meetings. Hematology and Medical Oncology staff have produced 350-400 publications in the past year.

The dominant strengths of the Cancer Institute include multidisciplinary programs for clinical care and research in benign hematology, bone marrow transplantation, solid tumor subspecialty care, lymphoma, leukemia, neuro-oncology, palliative medicine, experimental therapeutics and basic science cancer biology. In addition, a one-year fellowship is available for candidates board eligible in either hematology or medical oncology in the areas of bone marrow transplantation, experimental therapeutics, new drug development and multiple myeloma. These are research fellowships heavily weighted to include pharmacologic studies and laboratory research. We encourage applications from candidates who seek an outstanding training experience in academic hematology and medical oncology, with career goals in multidisciplinary research and subspecialty clinical care.

Graduates of U.S., Puerto Rican and Canadian medical schools planning certification in internal medicine by the ABIM and foreign medical graduates holding a valid ECFMG certificate are welcome to apply. The application process for fellowship is conducted through ERAS®. We are a participant of the NRMP Main Match and therefore, do not fill any positions outside of the Match. Applications will be accepted from July 1st through August 15th each year for positions to begin July 1st of the next academic year.

We encourage applicants to contact the Fellowship Coordinator regarding inquiries into our program.:

Lynn Mulgrew

Program Coordinator
Cleveland Clinic
Taussig Cancer Institute
Hematology/Medical Oncology
9500 Euclid Avenue (R35)
Cleveland, OH 44195
Phone: 216.445.0624
Fax: 216.444.9464

• Graduate Medical Education Website

• Graduate Physician Manual

The Cleveland Clinic is an equal opportunity employer. In addition, international medical graduates must meet visa requirements to pursue graduate medical education within the United States and Cleveland Clinic.

When Cleveland Clinic opened its doors in 1921, the goal of our founders was simple and straightforward: "Better care of the sick, investigation of their problems, and further education of those who serve." Today, Cleveland Clinic is home to more than 1,000 physicians, representing more than 100 specialties and subspecialties. Last year, Cleveland Clinic provided for nearly two million outpatient visits and almost 50,000 hospital admissions. We have grown exponentially in the past 82 years, but our three-fold mission has remained the same-excellence in patient care, research, and medical education.

At the Cleveland Clinic Taussig Cancer Institute, we understand the importance of preparing of the best each new generation of physician scientists to not only practice the art and science of oncology and hematology, but to contribute to its continuous improvement and development. The Hematology/Oncology Fellowship Program at Cleveland Clinic Taussig Cancer Institute, ensures that the cycle of knowledge progresses from research to education to patient care and back again.

Hematologic Oncology & Blood Disorders

• Brian Bolwell, MD, Chairman, Taussig Cancer Institute
• Mikkael Sekeres, MD, MS, Fellowship Program Director, Leukemia, MDS
• Anjali Advani, MD, Leukemia, MDS
• Edward Copelan, MD, Bone Marrow Transplant, Acute Leukemia
• Robert Dean, MD, Lymphoma , Bone Marrow Transplant
• Leonard Horwitz, MD, Benign Hematology
• Matt Kalaycio, MD, Director of Bone Marrow Transplant
• Omer Koc, MD, Lymphoma
• Anna Koo, MD, Aphaeresis
• Alan Lichtin, MD, Benign Hematology, Anemia
• Jarek Maciejewski, MD, Aplastic Anemia, MDS
• Brad Pohlman, MD, Lymphoma, Hodgkin’s Disease
• Frederic Reu, MD, Multiple Myeloma, Leukemia
• Yogen Saunthararajah, MD, Myelodysplastic Syndrome (MDS)
• Bernard Silver, MD, Benign Hematology, Clotting and Platelet Disorders
• Ronald Sobecks, MD, Leukemia, Bone Marrow Transplant
• John Sweetenham, MD, Lymphoma, Leukemia

Solid Tumor Oncology

• Robert Dreicer, MD, Chairman, Solid Tumor Oncology, GU Oncology
• Timothy Gilligan, MD, Fellowship Program Director, GU Oncology
• David Adelstein, MD, Head & Neck
• Steven Andresen, DO, Breast
• Ernest Borden, MD, Melanoma, Sarcoma
• G. Thomas Budd, MD, Breast
• Mellar Davis, MD, Palliative Medicine, Lung
• Jorge Garcia, MD, GU Oncology
• Terence Gutgsell, MD, Palliative Medicine
• Ruth Lagman, MD, Palliative Medicine
• Susan LeGrand, MD, Palliative Medicine
• Halle Moore, MD, Breast
• David Peereboom, MD, CNS, Brain Tumors
• Nathan Pennell, MD, Thoracic Oncology, Esophageal
• Robert Pelley, MD, GI Oncology
• Brian Rini, MD, GU Oncology
• Marc Shapiro, MD, GI Oncology, Breast
• Pierre Triozzi, MD, Melanoma
• T. Declan Walsh, MSc, FACP, FRCP, Palliative Medicine

Timothy D. Gilligan, MD, MS

Program Director
Cleveland Clinic
Taussig Cancer Institute
Hematology/Medical Oncology Fellowship Program
9500 Euclid Avenue (R35)
Cleveland, OH 44195
Phone: 216.444.0391

Lynn Mulgrew

Program Coordinator
Cleveland Clinic
Taussig Cancer Institute
Hematology/Medical Oncology
9500 Euclid Avenue (R35)
Cleveland, OH 44195
Phone: 216.445.0624
Fax: 216.444.9464